Personal Care
Personal Care
During the year we have for example launched washable absorbent underwear under TENA Silhouette and TENA for Men, an upgrade of Saba® Buenas Noches® pads in Mexico, and Lotus Baby Douceur Naturelle, which was awarded the “Product of the Year” prize in France.
Brands
Key figures
Net sales, SEKm
Sales growth1)
Organic sales growth2)
Adjusted EBITA margin3)
Adjusted return on capital employed3)
1) Including organic sales growth and acquisitions.
2) Excluding exchange rate effects, acquisitions and divestments.
3) Excluding items affecting comparability.
Offering
Essity’s offering includes Incontinence Products, Medical Solutions, Baby Care and Feminine Care. Products are sold under brands such as Actimove, TENA, JOBST, Leukoplast, Libero, Libresse, Nosotras, Saba and TOM Organic, and as retailer brands.
In Incontinence Products, with the globally leading brand TENA, Essity offers a broad range of incontinence products that also includes skincare products, wet wipes, wash gloves, washable absorbent underwear and digital solutions with sensor technology. In Baby Care, Essity offers open baby diapers and pant diapers as well as baby care products such as wet wipes, shampoo, lotion and baby oil. Essity’s offering for Baby Care in Europe is sold under its own Libero and Lotus brands and as retailer brands. In Feminine Care, Essity offers a broad product portfolio that includes pads, panty liners, tampons, intimate soaps, intimate wipes, washable absorbent underwear and reusable menstrual cups. In Medical Solutions, Essity offers products and services in wound care, compression therapy and orthopedics.
Distribution channels are the retail trade, pharmacies, medical device stores, hospitals, distributors and care institutions and e-commerce.
Market positions
Essity is the global market leader in the market for incontinence products with the TENA brand. Essity is the market leader in Europe and Latin America. Essity is the third largest player in Asia and the fourth largest in North America.
In Baby Care, Essity is the world’s fifth largest player and the second largest in Europe. Essity’s strongest market is the Nordic region, where the Libero brand is the market leader. Examples of other strong regional brands are Drypers in South East Asia and Pequeñin in South America.
In Feminine Care, Essity is the world’s fifth largest player, the third largest in Europe and the market leader in Latin America. Examples of regional brands supported by Essity’s global brand platform in Feminine Care include Libresse in the Nordic region, Russia, Eastern Europe, the Netherlands, Malaysia and China, Bodyform in the UK, Nana in France and the Middle East, Saba and Nosotras in Latin America and Libra and TOM Organic in Australasia.
In Medical Solutions, in the product categories in which the company is active, Essity is the world’s fourth largest player and the market leader in Europe. Essity is the largest global player in compression therapy and the third largest player in orthopedics. In wound care, which includes acute and advanced wound care, Essity is the sixth largest player. Essity holds the number three position within acute wound care. Examples of strong brands include JOBST, Leukoplast, Cutimed, Delta-Cast and Actimove.
Production facilities
At the end of 2021, Personal Care had production at 38 sites in 26 countries.
Operations in 2021
Net sales increased 1.2% to SEK 46,639m (46,095). The organic sales growth amounted to 5.0%, of which volume accounted for 2.7% and price/mix for 2.3%. Organic sales growth amounted to 2.8% in mature markets. In emerging markets, which accounted for 35% of net sales, organic sales growth amounted to 9.0%. Exchange rate effects reduced net sales by 4.2%. The acquisition of Asaleo Care increased net sales by 1.4%. Divestments reduced net sales by 1.0%.
For Incontinence Products, with Essity’s globally leading TENA brand, organic sales growth amounted to 3.5%. In Medical Solutions, organic sales growth amounted to 10.8%. For Baby Care, organic sales growth amounted to –0.6%. For Feminine Care, organic sales growth amounted to 10.0%.
The adjusted gross margin decreased 1.2 percentage points to 40.2% (41.4). Higher costs for raw materials and distribution had a negative impact on the margin. The margin was positively impacted by higher volumes, higher prices, a better mix and cost savings. The adjusted EBITA margin decreased 0.3 of a percentage point to 15.2% (15.5). Sales costs, excluding marketing costs, were lower also as a share of net sales. Marketing costs were higher but decreased as a share of net sales. Adjusted EBITA decreased 1% (increased 3% excluding currency translation effects, acquisitions and divestments) to SEK 7,098m (7,161).
Net sales
Earnings trend
3) Excluding items affecting comparability.
|
SEKm |
2021 |
2020 |
% |
||||||
|---|---|---|---|---|---|---|---|---|---|
|
Net sales |
46,639 |
46,095 |
1 |
||||||
|
Sales growth1), % |
6.4 |
0.3 |
|
||||||
|
Organic sales growth2), % |
5.0 |
0.0 |
|
||||||
|
Adjusted gross margin3), % |
40.2 |
41.4 |
|
||||||
|
Adjusted EBITA3) |
7,098 |
7,161 |
–1 |
||||||
|
Adjusted EBITA margin3), % |
15.2 |
15.5 |
|
||||||
|
Adjusted return on capital employed3), % |
16.3 |
16.4 |
|
||||||
|
Operating cash flow |
6,469 |
7,485 |
–14 |
||||||
|
Investments in non-current assets |
–1,779 |
–1,658 |
7 |
||||||
|
Average number of employees |
17,971 |
18,298 |
–2 |
||||||
|
|||||||||
Net sales
by product category
Net sales
by region
